These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 10412494)

  • 1. Action of chlorogenic acid on the complement system.
    Ejzemberg R; Da Silva MH; Pinto L; Mors WB
    An Acad Bras Cienc; 1999; 71(2):273-7. PubMed ID: 10412494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemolytic activity of leukemic sera: the role of complement and sucrose.
    Berchtold PE; Spaeth PJ; Haeberli A; Straub PW
    J Lab Clin Med; 1986 Jun; 107(6):544-50. PubMed ID: 3086472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complement-mediated killing of Vibrio species by the humoral fluids of amphioxus Branchiostoma belcheri: implications for a dual role of O-antigens in the resistance to bactericidal activity.
    Li Z; Zhang S; Wang C; Pang Q
    Fish Shellfish Immunol; 2008 Feb; 24(2):215-22. PubMed ID: 18178103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of the classic and alternate complement pathways by endotoxin.
    Fine DP
    J Immunol; 1974 Feb; 112(2):763-9. PubMed ID: 4205207
    [No Abstract]   [Full Text] [Related]  

  • 5. Blocking of the hemolytic expression of the classical complement sequence by products of complement activation via the alternate pathway. Materials responsible for the blocking phenomenon and their proposed mechanism of action.
    Koethe SM; Austen KF; Gigli I
    J Immunol; 1973 Feb; 110(2):390-400. PubMed ID: 4684033
    [No Abstract]   [Full Text] [Related]  

  • 6. Reconstruction of anti-leprosy drug depleted complement haemolytic activity by addition of zymosan-treated sera (a source of C142) and CratEDTA (a source of C3-C9).
    Kashyap A; Saha K; Sehgal VN
    Int J Immunopharmacol; 1992 Nov; 14(8):1409-14. PubMed ID: 1464472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alternative complement pathway in bovine serum: lysis of human erythrocytes.
    Pang AS; Aston WP
    Am J Vet Res; 1977 Mar; 38(3):355-9. PubMed ID: 403835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IgG and complement-mediated tissue damage in the absence of C2: evidence of a functionally active C2-bypass pathway in a guinea pig model.
    Wagner E; Platt JL; Howell DN; Marsh HC; Frank MM
    J Immunol; 1999 Sep; 163(6):3549-58. PubMed ID: 10477630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Consumption of complement in chelated and nonchelated guinea pig serum after challenge with some viral and nonviral interferon inducers.
    Rathová V; Kocisková D; Krizanová O; Borecký L
    Acta Virol; 1976 Feb; 20(1):86-8. PubMed ID: 7949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the effects of divalent ion chelating agents on complement-mediated hemolysis in rabbit and human serum.
    Marney SR; Des Prez RM
    J Immunol; 1969 Nov; 103(5):1044-9. PubMed ID: 4981793
    [No Abstract]   [Full Text] [Related]  

  • 11. [In vitro effect of rainbow trout (Oncorhynchus mykiss) serum in Tylodelphys sp. (trematoda, Diplosromatidae) metacercariae].
    Olabuenaga S
    Bol Chil Parasitol; 2000; 55(1-2):39-45. PubMed ID: 11757418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ability to activate the alternative complement pathway acquired by human and guinea-pig erythrocytes after contact with influenza virus.
    Lambré C; Thibon M
    Ann Immunol (Paris); 1980; 131C(2):213-21. PubMed ID: 7416718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiinflammatory effect of superoxide dismutase (SOD). Comparison between yeast and bovine SOD on some complement-mediated reactions in vitro and in vivo.
    Neychev H; Ivanovska N; Valeva V; Stefanova Z; Kuyumdjieva A
    Int J Tissue React; 1994; 16(3):131-7. PubMed ID: 7852034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The purification and reactivity of the first component of complement from guinea pig, human and canine sera.
    Tamura N; Nelson RA
    J Immunol; 1968 Dec; 101(6):1333-45. PubMed ID: 4972623
    [No Abstract]   [Full Text] [Related]  

  • 15. Identification and characterization of serum complement activity in the American crocodile (Crocodylus acutus).
    Merchant M; McFatter J; Mead S; McAdon C; Wasilewski J
    Vet Immunol Immunopathol; 2010 Feb; 133(2-4):165-9. PubMed ID: 19716182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of non-steroidal antiinflammatory drugs on some biological activities dependent on complement activation.
    Orsolini P; Milani MR; Velgi C
    Arzneimittelforschung; 1979; 29(2):179-81. PubMed ID: 375949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A drop of mink complement kills a mouse].
    Belkin ZP; Kozlov LV; Andina SS; Mishin AA; Guzova VA; D'iakov VL
    Vopr Med Khim; 2002; 48(4):373-7. PubMed ID: 12506613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetic studies of the formation of the properdin system enzymes on zymosan: evidence that nascent C3b controls the rate of assembly.
    Nicholson A; Brade V; Lee GD; Shin HS; Mayer MM
    J Immunol; 1974 Mar; 112(3):1115-23. PubMed ID: 4811964
    [No Abstract]   [Full Text] [Related]  

  • 19. Pathway-specific complement activity in pigs evaluated with a human functional complement assay.
    Salvesen B; Mollnes TE
    Mol Immunol; 2009 May; 46(8-9):1620-5. PubMed ID: 19328551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feline (cat) hemolytic complement optimal testing conditions.
    Barta O; Oyekan PP
    Am J Vet Res; 1981 Mar; 42(3):378-81. PubMed ID: 6791533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.